Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

Alexandre Wohlkonig, Pan F Chan, Andrew P Fosberry, Paul Homes, Jianzhong Huang, Michael Kranz, Vaughan R Leydon, Timothy J Miles, Neil D Pearson, Rajika L Perera, Anthony J Shillings, Michael N Gwynn, Benjamin D Bax

Research output: Contribution to journalArticlepeer-review

257 Citations (Scopus)

Abstract

Quinolone antibacterials have been used to treat bacterial infections for over 40 years. A crystal structure of moxifloxacin in complex with Acinetobacter baumannii topoisomerase IV now shows the wedge-shaped quinolone stacking between base pairs at the DNA cleavage site and binding conserved residues in the DNA cleavage domain through chelation of a noncatalytic magnesium ion. This provides a molecular basis for the quinolone inhibition mechanism, resistance mutations and invariant quinolone antibacterial structural features.

Original languageEnglish
Pages (from-to)1152-1153
Number of pages2
JournalNature Structural & Molecular Biology
Volume17
Issue number9
DOIs
Publication statusPublished - Sep 2010

Keywords

  • Acinetobacter baumannii/enzymology
  • DNA Topoisomerase IV/chemistry
  • Enzyme Inhibitors/chemistry
  • Models, Molecular
  • Protein Structure, Quaternary
  • Protein Structure, Tertiary
  • Quinolones/chemistry

Fingerprint

Dive into the research topics of 'Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance'. Together they form a unique fingerprint.

Cite this